Janice Staber
Pediatric Hematology-Oncology · Iowa City, IANPI 1013126705
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $128,819 of the $162,781 with a category attached, or 79.1%. 12 manufacturers reported payments, led by Sanofi at 47.7% of the total. Among pediatric hematology-oncology clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $1050.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$78K
- Genentech USA, Inc.$19K
- Bayer$18K
- Takeda Pharmaceuticals U.S.A., Inc.$15K
- Biomarin Pharmaceutical Inc.$10K
- Spark Therapeutics, Inc.$10K
- plus $15K from 6 others
Across 148 payments — averaging $5894.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$342K
- Sanofi US Services Inc.$178K
- Novo Nordisk AS$121K
- Bayer$77K
- Takeda Pharmaceuticals U.S.A., Inc.$70K
- Bioverativ Therapeutics Inc.$42K
- plus $43K from 2 others
What the payments were for
- Consulting fees$128,81979%
- Speaking & faculty fees$14,2179%
- Travel & lodging$15,51510%
- Food & beverage$4,1873%
- Education$430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 37 | $77,712 |
| Genentech USA, Inc. | 23 | $18,713 |
| Bayer | 33 | $17,976 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $14,702 |
| Biomarin Pharmaceutical Inc. | 10 | $9,574 |
| Spark Therapeutics, Inc. | 6 | $9,500 |
| Bioverativ Therapeutics Inc. | 6 | $4,317 |
| Sanofi-aventis U.S. LLC | 7 | $3,542 |
| Novo Nordisk | 2 | $2,975 |
| CSL Behring | 2 | $2,342 |
| Shire North American Group Inc | 9 | $1,391 |
| Pfizer | 3 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$162,781 in reported general payments places this provider in the 95th percentile of 21 pediatric hematology-oncology providers in Iowa.
Other pediatric hematology-oncology in Iowa City
- Anjali SharathkumarIowa City$61K
- David DickensIowa City$4K
- Julie FischerIowa City$157
- Sara HortonIowa City$142
- Christopher BarnettIowa City$139
- Jenna GedminasIowa City$123
- Beeling ArmijoIowa City$33
- Krista GrindeIowa City$14
- William TerryIowa City$13
- David GordonIowa City$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.